Phosphodiesterases and their inhibitors /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Liras, Spiros (Editor ), Bell, Andrew S. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Weinheim an der Bergstrasse, Germany : Wiley-VCH, 2014.
Colección:Methods and principles in medicinal chemistry ; Volume 61.
Temas:
Cyclic nucleotide phosphodiesterases.
Phosphodiesterases > Inhibitors.
Phosphodiesterases > Inhibitors > Therapeutic use.
Phosphodiesterase Inhibitors > chemistry
Phosphodiesterase Inhibitors > therapeutic use
Nucléotides cycliques phosphodiestérases.
Phosphodiestérases > Inhibiteurs.
Phosphodiestérases > Inhibiteurs > Emploi en thérapeutique.
MEDICAL > Physiology.
SCIENCE > Life Sciences > Human Anatomy & Physiology.
Cyclic nucleotide phosphodiesterases
Internet Resources.
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn878141373
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cn|||||||||
008 140325t20142014gw a ob 001 0 eng d
040 |a E7B  |b eng  |e rda  |e pn  |c E7B  |d N$T  |d YDXCP  |d DG1  |d CDX  |d EBLCP  |d IDEBK  |d SFB  |d DEBSZ  |d COO  |d DEBBG  |d OCLCQ  |d CASUM  |d COCUF  |d DG1  |d CHVBK  |d MOR  |d LIP  |d PIFBY  |d ZCU  |d MERUC  |d OCLCQ  |d OCLCO  |d CNCGM  |d OCLCA  |d U3W  |d OCLCA  |d DG1  |d OCLCQ  |d STF  |d OCLCF  |d ICG  |d INT  |d VT2  |d OCLCQ  |d TKN  |d UKMGB  |d OCLCQ  |d OCLCO  |d DKC  |d OCLCQ  |d UKAHL  |d UX1  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d TUHNV  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
016 7 |a 1044720972  |2 DE-101 
016 7 |a 016645180  |2 Uk 
016 7 |a 019195033  |2 Uk 
019 |a 874321908  |a 881423826  |a 961577287  |a 962694307  |a 1055403018  |a 1081267066  |a 1228564008 
020 |a 9783527682355  |q (electronic bk.) 
020 |a 352768235X  |q (electronic bk.) 
020 |a 9783527682348  |q (electronic bk.) 
020 |a 3527682341  |q (electronic bk.) 
020 |a 3527332197 
020 |a 9783527332199 
020 |a 9781306531955 
020 |a 1306531950 
020 |a 3527682376  |q (Mobi) 
020 |a 9783527682379  |q (Mobi) 
020 |a 3527682368  |q (ePub) 
020 |a 9783527682362  |q (ePub) 
020 |z 9783527332199 
020 |z 9783527682379  |q (Mobi) 
020 |z 9783527682362  |q (ePub) 
029 1 |a AU@  |b 000061131401 
029 1 |a CHBIS  |b 010259738 
029 1 |a CHNEW  |b 000943036 
029 1 |a CHVBK  |b 480232539 
029 1 |a DEBBG  |b BV042795782 
029 1 |a DEBBG  |b BV042989481 
029 1 |a DEBBG  |b BV043396710 
029 1 |a DEBBG  |b BV044067278 
029 1 |a DEBSZ  |b 431651620 
029 1 |a DEBSZ  |b 449419991 
029 1 |a DEBSZ  |b 475023528 
029 1 |a DEBSZ  |b 485047748 
029 1 |a GBVCP  |b 814301746 
029 1 |a UKMGB  |b 019195033 
035 |a (OCoLC)878141373  |z (OCoLC)874321908  |z (OCoLC)881423826  |z (OCoLC)961577287  |z (OCoLC)962694307  |z (OCoLC)1055403018  |z (OCoLC)1081267066  |z (OCoLC)1228564008 
037 |a 584446  |b MIL 
050 4 |a QP609.C92  |b .P467 2014eb 
060 4 |a W1  |b ME9613H v.61 2014 
060 4 |a QU 143 
072 7 |a MED  |x 075000  |2 bisacsh 
072 7 |a SCI  |x 036000  |2 bisacsh 
072 7 |a QP  |2 lcco 
082 0 4 |a 612.01519  |2 23 
049 |a UAMI 
245 0 0 |a Phosphodiesterases and their inhibitors /  |c edited by Spiros Liras and Andrew S. Bell. 
264 1 |a Weinheim an der Bergstrasse, Germany :  |b Wiley-VCH,  |c 2014. 
264 4 |c ©2014 
300 |a 1 online resource (238 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Methods and Principles in Medicinal Chemistry ;  |v Volume 61 
504 |a Includes bibliographical references at the end of each chapters and index. 
588 0 |a Print version record. 
505 0 |a Phosphodiesterases and Their Inhibitors; Contents; List of Contributors; Preface; A Personal Foreword; 1 Introduction; 2 Toward a New Generation of PDE5 Inhibitors through Advances in Medicinal Chemistry; 2.1 Introduction; 2.2 The First-Generation Agents; 2.3 PDE5 as a Mechanism and Alternative Indications Beyond MED; 2.4 A Summary of PDE5 Chemotypes Reported Post-2010; 2.5 Second-Generation PDE5 Inhibitors from Pfizer: Pyrazolopyrimidines; 2.6 Second-Generation PDE5 Inhibitors from Pfizer: Pyridopyrazinones; 2.7 Conclusions; References. 
505 8 |a 3 PDE4: New Structural Insights into the Regulatory Mechanism and Implications for the Design of Selective Inhibitors3.1 Introduction; 3.2 Isoforms, Domain Organization, and Splice Variants; 3.3 Structural Features of the Catalytic Site; 3.4 Regulation of PDE4 Activity; 3.5 Crystal Structure of Regulatory Domains of PDE4; 3.6 UCR2 Interaction and Selectivity; 3.7 Conclusions; References; 4 PDE4: Recent Medicinal Chemistry Strategies to Mitigate Adverse Effects; 4.1 Introduction; 4.2 Brief Summary of pan-PDE4 Inhibitors; 4.2.1 Rolipram; 4.2.2 Roflumilast; 4.2.3 Cilomilast; 4.2.4 Apremilast. 
505 8 |a 4.3 PDE4 Strategies to Avoid Gastrointestinal Events4.3.1 Allosteric Modulation; 4.3.2 PDE4D Selectivity; 4.3.3 Pfizer; 4.3.4 Novartis; 4.3.5 Merck-Frosst; 4.3.6 GEBR-7b; 4.3.7 PDE4B Selectivity; 4.3.8 Asahi Kasei; 4.3.9 GlaxoSmithKline; 4.3.10 Pfizer; 4.3.11 Tissue Targeting; 4.3.12 Polypharmacology; 4.3.13 Olanzapine Derivatives; 4.4 Conclusions; References; 5 The Function, Enzyme Kinetics, Structural Biology, and Medicinal Chemistry of PDE10A; 5.1 Enzymology and Protein Structure; 5.2 Papaverine-Related PDE10A Inhibitors; 5.3 MP-10/PF-2545920 Class of Inhibitors. 
505 8 |a 5.4 PF-2545920/MP-Inspired Inhibitors5.5 PF-2545920/Papaverine/Quinazoline Hybrid Series of Inhibitors; 5.6 PET Ligand Development; 5.7 Summary and Future; References; 6 The State of the Art in Selective PDE2A Inhibitor Design; 6.1 Introduction; 6.2 Selective PDE2A Inhibitors; 6.2.1 Bayer; 6.2.2 Altana AG; 6.2.3 Biotie Therapies; 6.2.4 Boehringer Ingelheim; 6.2.5 Janssen; 6.2.6 Lundbeck; 6.2.7 Merck; 6.2.8 Neuro3d; 6.2.9 Pfizer; 6.3 Methods; 6.4 Conclusions; References; 7 Crystal Structures of Phosphodiesterase 9A and Insight into Inhibitor Discovery; 7.1 Introduction. 
505 8 |a 7.2 Subtle Asymmetry of the PDE9 Dimer in the Crystals7.3 The Structure of the PDE9 Catalytic Domain; 7.4 Interaction of Inhibitors with PDE9; 7.5 Implication on Inhibitor Selectivity; References; 8 PDEs as CNS Targets: PDE9 Inhibitors for Cognitive Deficit Diseases; 8.1 PDE9A Enzymology and Pharmacology; 8.2 Crystal Structures of PDE9A Inhibitors; 8.3 Medicinal Chemistry Efforts toward Identifying PDE9A Inhibitors for Treating Cognitive Disorders; 8.3.1 Bayer; 8.3.2 Pfizer; 8.3.3 Boehringer Ingelheim; 8.3.4 Sun Yat-Sen University, China; 8.3.5 Envivo Pharmaceuticals. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Cyclic nucleotide phosphodiesterases. 
650 0 |a Phosphodiesterases  |x Inhibitors. 
650 0 |a Phosphodiesterases  |x Inhibitors  |x Therapeutic use. 
650 1 2 |a Phosphodiesterase Inhibitors  |x chemistry 
650 2 2 |a Phosphodiesterase Inhibitors  |x therapeutic use 
650 6 |a Nucléotides cycliques phosphodiestérases. 
650 6 |a Phosphodiestérases  |x Inhibiteurs. 
650 6 |a Phosphodiestérases  |x Inhibiteurs  |x Emploi en thérapeutique. 
650 7 |a MEDICAL  |x Physiology.  |2 bisacsh 
650 7 |a SCIENCE  |x Life Sciences  |x Human Anatomy & Physiology.  |2 bisacsh 
650 7 |a Cyclic nucleotide phosphodiesterases  |2 fast 
655 4 |a Internet Resources. 
700 1 |a Liras, Spiros,  |e editor. 
700 1 |a Bell, Andrew S.,  |e editor. 
758 |i has work:  |a Phosphodiesterases and their inhibitors (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGXdtTfmYrPwhDhccbh8md  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Phosphodiesterases and their inhibitors.  |d Weinheim an der Bergstrasse, Germany : Wiley-VCH, ©2014  |h xviii, 218 pages  |k Methods and principles in medicinal chemistry ; Volume 61  |z 9783527332199 
830 0 |a Methods and principles in medicinal chemistry ;  |v Volume 61. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1650854  |z Texto completo 
936 |a BATCHLOAD 
938 |a Askews and Holts Library Services  |b ASKH  |n AH26323862 
938 |a Askews and Holts Library Services  |b ASKH  |n AH26323861 
938 |a Coutts Information Services  |b COUT  |n 27828099 
938 |a EBL - Ebook Library  |b EBLB  |n EBL1650854 
938 |a ebrary  |b EBRY  |n ebr10849214 
938 |a EBSCOhost  |b EBSC  |n 714680 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis27828099 
938 |a YBP Library Services  |b YANK  |n 11711372 
938 |a YBP Library Services  |b YANK  |n 11337244 
938 |a YBP Library Services  |b YANK  |n 12679632 
994 |a 92  |b IZTAP 

Ejemplares similares